Anton Pottegård

Klinisk farmaceut, ph.d.

  • J. B. Winsløws Vej 19, 2.

    5000 Odense C

    Danmark

20102019
Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 2010 2019

Filtrer
Kommentar/debat
2018
2 Downloads (Pure)
Åben adgang
Fil
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pharmaceutical Preparations
Pharmacoepidemiology
Drug Utilization
Safety
Pharmaceutical Preparations
clopidogrel

Enough power to build a strong case for clinical pharmacy services? In reply

Hallas, J., Ravn-Nielsen, L. V. & Pottegård, A., 1. jun. 2018, I : JAMA Internal Medicine. 178, 6, s. 864-865

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Hydrochlorothiazide and the Risk of Malignant Melanoma - Reply

Pottegård, A. & Gaist, D., 1. okt. 2018, I : JAMA Internal Medicine. 178, 10, s. 1425-1426

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Reuse of data sources to evaluate drug safety signals: When is it appropriate?

Wang, S. V., Kulldorff, M., Glynn, R. J., Gagne, J. J., Pottegård, A., Rothman, K. J., Schneeweiss, S. & Walker, A. M., jun. 2018, I : Pharmacoepidemiology and Drug Safety. 27, 6, s. 567-569

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

2016

Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban

Hellfritzsch, M., Damkier, P., Pottegård, A., Grønlykke, T. & Grove, E. L., mar. 2016, I : Pharmacoepidemiology and Drug Safety. 25, 3, s. 346-348

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Re: Pregabalin prescriptions in the United Kingdom – a drug utilisation study of The Health Improvement Network (THIN) primary care database by Asomaning et al.

Pottegård, A., Tjäderborn, M., Schjerning, O., Nielsen, J., Damkier, P. & Bodén, R., 2016, I : International Journal of Clinical Practice. 70, 8, s. 696 1 s.

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Drug Utilization
Prescriptions
Primary Health Care
Databases
Health
50 Downloads (Pure)

Time for integrating clinical, lifestyle and molecular data to predict drug responses: Authors' reply

Pottegård, A., Friis, S., Christensen, R. D., Habel, L. A., Gagne, J. J. & Hallas, J., 2016, I : EBioMedicine. 7, s. 11

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Åben adgang
Fil
2015

Editorial. Anti-secretory therapy prior to anti-reflux surgery: Does dose matter? Authors' reply

Lødrup, A., Pottegård, A., Hallas, J. & Bytzer, P., sep. 2015, I : Alimentary Pharmacology and Therapeutics. 42, 5, s. 627

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Response to the Letter: "Epidemiologic Association Between Antibiotic Use With the Risk of Developing Type 2 Diabetes" by López-Hernández, D

Mikkelsen, K. H., Knop, F. K., Nielsen, M. F. M., Hallas, J. & Pottegård, A., nov. 2015, I : Journal of Clinical Endocrinology and Metabolism. 100, 11, s. L121 1 s.

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Åben adgang
2014

Letter to the Editor: Danish ADHD data sets

Pottegård, A., Hallas, J., Hernández-Díaz, S. & Zoëga, H., dec. 2014, I : Journal of Child Psychology & Psychiatry. 55, 12, s. e6 1 s.

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review